AU2002223349A1 - Incorporation and priming function of trnalys in hiv and related viruses - Google Patents

Incorporation and priming function of trnalys in hiv and related viruses

Info

Publication number
AU2002223349A1
AU2002223349A1 AU2002223349A AU2334902A AU2002223349A1 AU 2002223349 A1 AU2002223349 A1 AU 2002223349A1 AU 2002223349 A AU2002223349 A AU 2002223349A AU 2334902 A AU2334902 A AU 2334902A AU 2002223349 A1 AU2002223349 A1 AU 2002223349A1
Authority
AU
Australia
Prior art keywords
trnalys
hiv
incorporation
related viruses
priming function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223349A
Inventor
Shan Cen
Lawrence Kleiman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU2002223349A1 publication Critical patent/AU2002223349A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
AU2002223349A 2000-11-28 2001-11-27 Incorporation and priming function of trnalys in hiv and related viruses Abandoned AU2002223349A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25314600P 2000-11-28 2000-11-28
US60/253,146 2000-11-28
PCT/CA2001/001700 WO2002044349A2 (en) 2000-11-28 2001-11-27 INCORPORATION AND PRIMING FUNCTION OF tRNALYS IN HIV AND RELATED VIRUSES

Publications (1)

Publication Number Publication Date
AU2002223349A1 true AU2002223349A1 (en) 2002-06-11

Family

ID=22959058

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223349A Abandoned AU2002223349A1 (en) 2000-11-28 2001-11-27 Incorporation and priming function of trnalys in hiv and related viruses

Country Status (3)

Country Link
US (1) US20040082068A1 (en)
AU (1) AU2002223349A1 (en)
WO (1) WO2002044349A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902439A1 (en) * 2006-06-14 2007-12-21 Univ Rene Descartes Paris V Et CHIMERIC TRANSFER RNA AND USE THEREOF FOR THE PRODUCTION OF RNA BY A CELL
US7598040B2 (en) * 2006-11-22 2009-10-06 Trana Discovery, Inc. Compositions and methods for the identification of inhibitors of protein synthesis
CN101855351A (en) * 2007-09-14 2010-10-06 特拉纳探索公司 Compositions and methods for the identification of inhibitors of retroviral infection
US8609609B2 (en) * 2008-01-18 2013-12-17 North Carolina State University Peptides and methods of use as therapeutics and screening agents
US20110229920A1 (en) * 2008-09-29 2011-09-22 Trana Discovery, Inc. Screening methods for identifying specific staphylococcus aureus inhibitors
CN103118692A (en) 2010-04-26 2013-05-22 Atyr医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
CA2797259C (en) 2010-04-27 2020-09-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
AU2011248614B2 (en) 2010-04-27 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
CN103097524B (en) * 2010-04-28 2016-08-03 Atyr医药公司 The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Alanyl-tRNA synthetase finds
CN103118693B (en) 2010-04-29 2017-05-03 Atyr 医药公司 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
US8986680B2 (en) 2010-04-29 2015-03-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
JP6039546B2 (en) 2010-05-03 2016-12-07 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of seryl tRNA synthetase
EP2566496B1 (en) 2010-05-03 2018-02-28 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
EP2566495B1 (en) 2010-05-03 2017-03-01 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
EP2566515B1 (en) 2010-05-03 2017-08-02 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
CA2798301C (en) 2010-05-04 2020-09-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases
AU2011248101B2 (en) 2010-05-04 2016-10-20 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex
CA2799197C (en) 2010-05-14 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
EP2575856B1 (en) 2010-05-27 2017-08-16 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
EP2575857B1 (en) 2010-06-01 2018-01-24 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
AU2011279392C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases
JP6116479B2 (en) 2010-07-12 2017-04-19 エータイアー ファーマ， インコーポレイテッド Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glycyl-tRNA synthetase
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
KR20130102534A (en) 2010-07-12 2013-09-17 에이티와이알 파마, 인코포레이티드 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
US9029506B2 (en) 2010-08-25 2015-05-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases
JP6039566B2 (en) 2010-10-06 2016-12-07 エータイアー ファーマ， インコーポレイテッド Innovative discovery of tryptophanyl tRNA synthetase protein fragments related to therapeutic, diagnostic and antibody compositions
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
US9688978B2 (en) 2011-12-29 2017-06-27 Atyr Pharma, Inc. Aspartyl-tRNA synthetase-Fc conjugates
CN105378075B (en) 2013-03-15 2022-04-05 Atyr 医药公司 Histidyl-TRNA synthetase-FC conjugates
EP3612215A4 (en) 2017-04-20 2021-05-26 aTyr Pharma, Inc. Compositions and methods for treating lung inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP0558697A1 (en) * 1991-06-28 1993-09-08 Massachusetts Institute Of Technology Localized oligonucleotide therapy

Also Published As

Publication number Publication date
US20040082068A1 (en) 2004-04-29
WO2002044349A3 (en) 2003-01-03
WO2002044349A2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2002223349A1 (en) Incorporation and priming function of trnalys in hiv and related viruses
AUPQ801700A0 (en) Enzyme and viral activation
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002223599A1 (en) Pyrimidinone derivatives and their use in the treatment of atherosclerosis
AU2001289823A1 (en) Virus protection in an internet environment
AU2002221749A1 (en) Synthetic viruses and uses thereof
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
AU2001238501A1 (en) Selective destruction of cells infected with human immunodeficiency virus
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU5137800A (en) Cd4-independent hiv envelope proteins as vaccines and therapeutics
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001292667A1 (en) Immunogenic composition of hepatitis c and methods of use thereof
AU2001240018A1 (en) Adeno-associated viral compositions and methods
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001293048A1 (en) Antiviral compositions and methods of use
AU3732500A (en) Beclin and uses thereof
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001267239A1 (en) Viral phospholipase a2 enzymes, anti-viral agents and methods of use
AU2001276258A1 (en) Ceramic component and the use thereof
AU2002212327A1 (en) Pharmaceutical preparation comprised of milk-thistle and terpenes
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof